|
EFR3A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64789999979043E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.00109999956466E-07 |
| Normal-vs-Stage2 |
2.441700E-02 |
| Normal-vs-Stage3 |
1.178510E-03 |
| Normal-vs-Stage4 |
1.116680E-03 |
| Stage1-vs-Stage2 |
4.332800E-01 |
| Stage1-vs-Stage3 |
1.808560E-01 |
| Stage1-vs-Stage4 |
6.702800E-01 |
| Stage2-vs-Stage3 |
8.821400E-01 |
| Stage2-vs-Stage4 |
7.646800E-01 |
| Stage3-vs-Stage4 |
5.712600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.32649999768009E-08 |
| Normal-vs-AfricanAmerican |
8.316500E-03 |
| Normal-vs-Asian |
1.123200E-03 |
| Caucasian-vs-AfricanAmerican |
9.662800E-01 |
| Caucasian-vs-Asian |
6.931200E-01 |
| AfricanAmerican-vs-Asian |
8.120600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.362170E-03 |
| Normal-vs-Female |
4.04179999469179E-08 |
| Male-vs-Female |
4.680300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.25679999962713E-07 |
| Normal-vs-Age(41-60Yrs) |
3.21260000002432E-06 |
| Normal-vs-Age(61-80Yrs) |
1.533740E-02 |
| Normal-vs-Age(81-100Yrs) |
3.103200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.291200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.990300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.501000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.794830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.823200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.536000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.056400E-01 |
| Classical-VS-Follicular |
3.2140999994823E-07 |
| Classical-VS-Other |
1.465160E-01 |
| Classical-VS-Normal |
7.17530035387881E-10 |
| Tall-VS-Follicular |
8.017700E-04 |
| Tall-VS-Other |
1.173040E-01 |
| Tall-VS-Normal |
1.621470E-04 |
| Follicular-VS-Other |
8.423400E-01 |
| Follicular-VS-Normal |
5.108200E-01 |
| Other-VS-Normal |
5.617000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.370100E-04 |
| Normal-vs-N1 |
6.758100E-03 |
| N0-vs-N1 |
7.568600E-01 |
|
|
